6-29173765-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030905.3(OR2J2):āc.130C>Gā(p.Leu44Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,613,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030905.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2J2 | NM_030905.3 | c.130C>G | p.Leu44Val | missense_variant | 2/2 | ENST00000641417.1 | NP_112167.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2J2 | ENST00000641417.1 | c.130C>G | p.Leu44Val | missense_variant | 2/2 | NM_030905.3 | ENSP00000493401 | P1 | ||
OR2J2 | ENST00000377167.3 | c.130C>G | p.Leu44Val | missense_variant | 1/1 | ENSP00000366372 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151860Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000401 AC: 10AN: 249464Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135338
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461792Hom.: 0 Cov.: 30 AF XY: 0.0000248 AC XY: 18AN XY: 727190
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151860Hom.: 0 Cov.: 31 AF XY: 0.0000674 AC XY: 5AN XY: 74172
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2022 | The c.130C>G (p.L44V) alteration is located in exon 1 (coding exon 1) of the OR2J2 gene. This alteration results from a C to G substitution at nucleotide position 130, causing the leucine (L) at amino acid position 44 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at